Zolbetuximab in Gastric or Gastroesophageal Junction Adenocarcinoma

MeSH terms

• Adenocarcinoma* / drug therapy
• Adenocarcinoma* / pathology
• Adult
• Aged
• Aged, 80 and over
• Antibodies, Monoclonal / administration & dosage
• Antibodies, Monoclonal / adverse effects
• Antineoplastic Combined Chemotherapy Protocols / administration & dosage
• Antineoplastic Combined Chemotherapy Protocols / adverse effects
• Clinical Trials, Phase III as Topic
• Esophageal Neoplasms* / drug therapy
• Esophageal Neoplasms* / mortality
• Esophageal Neoplasms* / pathology
• Esophagogastric Junction* / pathology
• Female
• Humans
• Male
• Middle Aged
• Multicenter Studies as Topic
• Nausea / chemically induced
• Nausea / epidemiology
• Progression-Free Survival
• Randomized Controlled Trials as Topic
• Stomach Neoplasms* / drug therapy
• Stomach Neoplasms* / mortality
• Stomach Neoplasms* / pathology
• Vomiting / chemically induced
• Vomiting / epidemiology
• Young Adult